Skip to main content
Caplight Logo









SignalChem Lifesciences Corporation

SignalChem Lifesciences Corporation

Private
Richmond, British ColumbiaHealthcare & Life Scienceshttps://signalchemlifesciences.com

Last Round

Strategic

Sep 24, 2021

Total Funding Raised

$13M

Company Overview

SignalChem Lifesciences Corporation operates in Healthcare & Life Sciences and is based in Richmond, British Columbia. Its latest recorded funding round was a Strategic round in September 2021.

SignalChem Lifesciences Corporation is a biotechnology company that develops novel small-molecule targeted therapies for the treatment of cancer, inflammation, and central nervous system diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

SignalChem Lifesciences Corporation Comparables

Compare SignalChem Lifesciences Corporation with similar companies based on industry and business-model similarity.

SignalChem Lifesciences Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BerGenBio ASA
82%
Pacylex Pharmaceuticals
79%
Carna Biosciences, Inc.
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

SignalChem Lifesciences Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicSep 24, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jun Yan

CEO and President

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors increased 282% MoM.

  • Oct 30, 2024

    Monthly visitors grew 69% MoM, from 501 to 847.

Book a demo to see all signals

For institutional investors. Book with your work email.

SignalChem Lifesciences Corporation Filings

Explore SEC and related filing metadata, where available.

SignalChem Lifesciences Corporation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about SignalChem Lifesciences Corporation's valuation, stock price, and market status.

Is SignalChem Lifesciences Corporation a public or private company?

SignalChem Lifesciences Corporation is a private company.

What is the current stock price of SignalChem Lifesciences Corporation?

SignalChem Lifesciences Corporation is a private company, so its shares have no public market price. Caplight tracks SignalChem Lifesciences Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is SignalChem Lifesciences Corporation worth (valuation)?

Valuation information for SignalChem Lifesciences Corporation is not publicly available.

Can I buy SignalChem Lifesciences Corporation stock?

SignalChem Lifesciences Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was SignalChem Lifesciences Corporation's last funding round?

SignalChem Lifesciences Corporation's most recent funding round was Strategic on September 24, 2021.

Who are the main investors in SignalChem Lifesciences Corporation?

Investor information for SignalChem Lifesciences Corporation is not publicly disclosed.

Will SignalChem Lifesciences Corporation IPO soon?

No public IPO plans have been announced for SignalChem Lifesciences Corporation.

How can I track SignalChem Lifesciences Corporation secondary market activity?

Caplight tracks bids, offers, and trades in SignalChem Lifesciences Corporation's shares on secondary markets.

Firmographic Details

HeadquartersRichmond, British Columbia
Employee Range18
Year Founded2012
Last FundingSep 24, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?